article thumbnail

Torrent Pharma to acquire Curatio for $245.16m

Pharmaceutical Technology

Indian company Torrent Pharmaceuticals has signed a definitive agreement for the complete acquisition of Curatio Healthcare for $245.16m (Rs20bn). A flagship company of the Torrent Group, Torrent Pharmaceuticals is a speciality-focused firm with more than 74% of its revenue from chronic and sub-chronic therapies in India.

article thumbnail

PharmaTher and Vitruvias partner to commercialise Ketarx in US

Pharmaceutical Technology

We are focused on building a network of strong commercial partnerships with leading speciality generic companies that are experienced in marketing, sales and distribution to the hospital, institutional and clinic channels within their territories. “We

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

ZyVersa Therapeutics enters SPAC merger deal with Larkspur

Pharmaceutical Technology

ZyVersa Therapeutics has signed a definitive business combination agreement with blank-check special purpose acquisition company (SPAC) Larkspur Health Acquisition. The deal, which will make ZyVersa a publicly traded biopharma company, values the merged entity at an estimated pro forma enterprise value of nearly $108.92m.

article thumbnail

Consumer-first digital pharma’s focus in 2023, says Graphite Digital report

pharmaphorum

As two in five pharma leaders say that moving to a consumer-first mindset is a priority for the next two years, digital customer experience agency Graphite Digital is to publish a special edition of its Contradiction Conundrum whitepaper report, released in partnership with Reuters Events Pharma last year. What is your definition of success?

Pharma 52
article thumbnail

Shear-Thinning Biomaterial for Embolic Applications: Interview with Upma Sharma, President and CEO of Arsenal Medical

Medgadget

The market’s current leading liquid embolic contains a solvent, dimethyl sulfoxide (DMSO), which can cause pain upon injection, necessitating the use of anesthesia and special compatible catheters. Medgadget: Does the material require a specialized delivery device? How is it delivered, and how do you prevent device blockage?

Medical 69
article thumbnail

Chiesi Farmaceutici to acquire Amryt Pharma for $1.48bn

Pharmaceutical Technology

Italian pharmaceutical company Chiesi Farmaceutici has signed a definitive agreement to acquire Amryt Pharma in a total deal valued at up to $1.48bn. Chiesi Farmaceutici researches, develops and markets innovative therapeutic solutions in rare diseases, respiratory health, and speciality care areas.

Pharma 52
article thumbnail

Intrinsic Medicine enters merger with Phoenix Biotech

Pharmaceutical Technology

Intrinsic Medicine has signed a definitive business combination agreement with special purpose acquisition (SPAC) firm Phoenix Biotech Acquisition to create a public company. The merged business will use human milk biology for the treatment of Gut-Brain Axis (GBA) disorders. in cash held in trust to Intrinsic. .